209 related articles for article (PubMed ID: 37376742)
1. Prognostic Value of Serum Biomarkers in Patients With Moderate-Severe Traumatic Brain Injury, Differentiated by Marshall Computer Tomography Classification.
Richter S; Czeiter E; Amrein K; Mikolic A; Verheyden J; Wang K; Maas AIR; Steyerberg E; Büki A; Menon DK; Newcombe VFJ
J Neurotrauma; 2023 Nov; 40(21-22):2297-2310. PubMed ID: 37376742
[TBL] [Abstract][Full Text] [Related]
2. Serum biomarkers identify critically ill traumatic brain injury patients for MRI.
Richter S; Winzeck S; Czeiter E; Amrein K; Kornaropoulos EN; Verheyden J; Sugar G; Yang Z; Wang K; Maas AIR; Steyerberg E; Büki A; Newcombe VFJ; Menon DK;
Crit Care; 2022 Nov; 26(1):369. PubMed ID: 36447266
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study.
Korley FK; Jain S; Sun X; Puccio AM; Yue JK; Gardner RC; Wang KKW; Okonkwo DO; Yuh EL; Mukherjee P; Nelson LD; Taylor SR; Markowitz AJ; Diaz-Arrastia R; Manley GT;
Lancet Neurol; 2022 Sep; 21(9):803-813. PubMed ID: 35963263
[TBL] [Abstract][Full Text] [Related]
4. Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 as Outcome Predictors in Traumatic Brain Injury.
Takala RS; Posti JP; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Kyllönen A; Maanpää HR; Tallus J; Hossain MI; Coles JP; Hutchinson P; van Gils M; Menon DK; Tenovuo O
World Neurosurg; 2016 Mar; 87():8-20. PubMed ID: 26547005
[TBL] [Abstract][Full Text] [Related]
5. Blood biomarkers on admission in acute traumatic brain injury: Relations to severity, CT findings and care path in the CENTER-TBI study.
Czeiter E; Amrein K; Gravesteijn BY; Lecky F; Menon DK; Mondello S; Newcombe VFJ; Richter S; Steyerberg EW; Vyvere TV; Verheyden J; Xu H; Yang Z; Maas AIR; Wang KKW; Büki A;
EBioMedicine; 2020 Jun; 56():102785. PubMed ID: 32464528
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Utility of Glial Fibrillary Acidic Protein Beyond 12 Hours After Traumatic Brain Injury: A TRACK-TBI Study.
Puccio AM; Yue JK; Korley FK; Okonkwo DO; Diaz-Arrastia R; Yuh EL; Ferguson AR; Mukherjee P; Wang KKW; Taylor SR; Deng H; Markowitz AJ; Sun X; Jain S; Manley GT
J Neurotrauma; 2024 Jun; 41(11-12):1353-1363. PubMed ID: 38251868
[TBL] [Abstract][Full Text] [Related]
7. Simplifying the use of prognostic information in traumatic brain injury. Part 2: Graphical presentation of probabilities.
Murray GD; Brennan PM; Teasdale GM
J Neurosurg; 2018 Jun; 128(6):1621-1634. PubMed ID: 29631517
[TBL] [Abstract][Full Text] [Related]
8. Incremental prognostic value of acute serum biomarkers for functional outcome after traumatic brain injury (CENTER-TBI): an observational cohort study.
Helmrich IRAR; Czeiter E; Amrein K; Büki A; Lingsma HF; Menon DK; Mondello S; Steyerberg EW; von Steinbüchel N; Wang KKW; Wilson L; Xu H; Yang Z; van Klaveren D; Maas AIR;
Lancet Neurol; 2022 Sep; 21(9):792-802. PubMed ID: 35963262
[TBL] [Abstract][Full Text] [Related]
9. Relationship of admission blood proteomic biomarkers levels to lesion type and lesion burden in traumatic brain injury: A CENTER-TBI study.
Whitehouse DP; Monteiro M; Czeiter E; Vyvere TV; Valerio F; Ye Z; Amrein K; Kamnitsas K; Xu H; Yang Z; Verheyden J; Das T; Kornaropoulos EN; Steyerberg E; Maas AIR; Wang KKW; Büki A; Glocker B; Menon DK; Newcombe VFJ;
EBioMedicine; 2022 Jan; 75():103777. PubMed ID: 34959133
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and Diagnostic Utility of Serum Biomarkers in Pediatric Traumatic Brain Injury.
Munoz Pareja JC; de Rivero Vaccari JP; Chavez MM; Kerrigan M; Pringle C; Guthrie K; Swaby K; Coto J; Kobeissy F; Avery KL; Ghosh S; Dhanashree R; Shanmugham P; Lautenslager LA; Faulkenberry S; Pareja Zabala MC; Al Fakhri N; Loor-Torres R; Governale LS; Blatt JE; Gober J; Perez PK; Solano J; McCrea H; Thorson C; O'Phelan KH; Keane RW; Dietrich WD; Wang KK
J Neurotrauma; 2024 Jan; 41(1-2):106-122. PubMed ID: 37646421
[TBL] [Abstract][Full Text] [Related]
11. Predicted Unfavorable Neurologic Outcome Is Overestimated by the Marshall Computed Tomography Score, Corticosteroid Randomization After Significant Head Injury (CRASH), and International Mission for Prognosis and Analysis of Clinical Trials in Traumatic Brain Injury (IMPACT) Models in Patients with Severe Traumatic Brain Injury Managed with Early Decompressive Craniectomy.
Charry JD; Tejada JH; Pinzon MA; Tejada WA; Ochoa JD; Falla M; Tovar JH; Cuellar-Bahamón AM; Solano JP
World Neurosurg; 2017 May; 101():554-558. PubMed ID: 28223249
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Models for Global Functional Outcome and Post-Concussion Symptoms Following Mild Traumatic Brain Injury: A Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) Study.
Mikolić A; Steyerberg EW; Polinder S; Wilson L; Zeldovich M; von Steinbuechel N; Newcombe VFJ; Menon DK; van der Naalt J; Lingsma HF; Maas AIR; van Klaveren D
J Neurotrauma; 2023 Aug; 40(15-16):1651-1670. PubMed ID: 37078144
[TBL] [Abstract][Full Text] [Related]
13. Admission levels of serum biomarkers have additive and cumulative prognostic value in traumatic brain injury.
Kaaber IA; Lesbo M; Wichmann TO; Olsen DA; Rasmussen MM; Brink O; Borris LC; Hviid CVB
Sci Rep; 2024 Jun; 14(1):14139. PubMed ID: 38898030
[TBL] [Abstract][Full Text] [Related]
14. Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study.
Bazarian JJ; Biberthaler P; Welch RD; Lewis LM; Barzo P; Bogner-Flatz V; Gunnar Brolinson P; Büki A; Chen JY; Christenson RH; Hack D; Huff JS; Johar S; Jordan JD; Leidel BA; Lindner T; Ludington E; Okonkwo DO; Ornato J; Peacock WF; Schmidt K; Tyndall JA; Vossough A; Jagoda AS
Lancet Neurol; 2018 Sep; 17(9):782-789. PubMed ID: 30054151
[TBL] [Abstract][Full Text] [Related]
15. Simplifying the use of prognostic information in traumatic brain injury. Part 1: The GCS-Pupils score: an extended index of clinical severity.
Brennan PM; Murray GD; Teasdale GM
J Neurosurg; 2018 Jun; 128(6):1612-1620. PubMed ID: 29631516
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury.
Papa L; Akinyi L; Liu MC; Pineda JA; Tepas JJ; Oli MW; Zheng W; Robinson G; Robicsek SA; Gabrielli A; Heaton SC; Hannay HJ; Demery JA; Brophy GM; Layon J; Robertson CS; Hayes RL; Wang KK
Crit Care Med; 2010 Jan; 38(1):138-44. PubMed ID: 19726976
[TBL] [Abstract][Full Text] [Related]
17. Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children.
Metzger RR; Sheng X; Niedzwecki CM; Bennett KS; Morita DC; Zielinski B; Schober ME
J Neurosurg Pediatr; 2018 Oct; 22(4):369-374. PubMed ID: 29957142
[TBL] [Abstract][Full Text] [Related]
18. A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury.
Thelin E; Al Nimer F; Frostell A; Zetterberg H; Blennow K; Nyström H; Svensson M; Bellander BM; Piehl F; Nelson DW
J Neurotrauma; 2019 Oct; 36(20):2850-2862. PubMed ID: 31072225
[TBL] [Abstract][Full Text] [Related]
19. Utility of the Marshall & Rotterdam Classification Scores in Predicting Outcomes in Trauma Patients.
Elkbuli A; Shaikh S; McKenney K; Shanahan H; McKenney M; McKenney K
J Surg Res; 2021 Aug; 264():194-198. PubMed ID: 33838403
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of novel computerized tomography scoring systems in human traumatic brain injury: An observational, multicenter study.
Thelin EP; Nelson DW; Vehviläinen J; Nyström H; Kivisaari R; Siironen J; Svensson M; Skrifvars MB; Bellander BM; Raj R
PLoS Med; 2017 Aug; 14(8):e1002368. PubMed ID: 28771476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
